Publications

Portfolio and research documents published by Vivameda Ltd, the company Oliver Nold (Oli Nold) founded and leads. Each document carries the publisher's own control number, which makes a specific version citable.

All three are company-controlled primary sources: they establish what Vivameda Ltd and its founder published on a stated date, and they are legitimate primary material about the company. They are not independent corroboration of the facts stated inside them. Where a document's narrative summary of Oliver Nold's earlier ventures differs from the registry-dated career record, the registry-dated record governs; the differences are stated per document below.

pub-founder-portfolio-2026 · VMD.21962.150826.301

Oliver Nold — Founder Portfolio

The operator behind the panel: a decade of owned companies, then one instrument.

Publisher: Vivameda Ltd, Cyprus
Author: Oliver Nold (Oli Nold)
Issued: August 2026
Extent: 10 pages, PDF (96 KB)
Purpose: Founder-level profile document setting out Oliver Nold's operating history before Vivameda Ltd, what the company is, the capability areas he works in, the operating model, and a short biography with contact details.
Evidence classification: Company-controlled primary source
Source record: S-025

Contents, as published

01 The operator — how the longitudinal workforce panel and its commercial architecture came out of a decade of owned companies.
02 The company — what Vivameda Ltd is in one page: the asset, the decisions it feeds, who it is for, and the classification rules the company states do not move.
03 What came before — narrative summary of prior ventures: cloud software, a growth and community agency, a measurement and attribution practice, a technology platform for remote professionals, consumer commerce, NORTH Resolutions, and advisory work.
04 Selected record — ten entries the document describes as verifiable: a built company, an existing document, or an executed agreement.
05 Where the work sits — data and panel architecture, research and analysis, commercial execution.
06 In their words — two attributed statements written in August 2026 by a client and a counterparty.
07 Operating model — founder-led concierge delivery: narrow question first, sample before scale, constraint stated first.
08 Profile and contact — short biography, company, email, website, LinkedIn, languages.

Figures stated in the document

Companies in the panel: 4M+ across 100+ countries
Observed company-year records: 48M, 1950 to 2026
Skill rows: 1.88B across 46.5M capability buckets
Data layers: 2, reported separately and never netted
Research studies published in 2026: 5
Engagements delivered February to August 2026: 25

Reproduced as company statements. No independent audit of these figures is recorded in the source ledger.

How to read this document

The document's “what came before” section is a narrative summary written for a commercial audience. Its period ranges (for example cloud software 2015–2017, technology platform 2018–2021, NORTH Resolutions 2020–2025) are the company's own framing and are not registry-dated. Where they differ from the dated career record on this site — which sources the beatmix ag title from 2011–2012, the NORTH Resolutions LLC formation from the Florida register (25 July 2023) and its dissolution (9 July 2025) — the registry-dated record governs.
Several prior ventures are described generically (“cloud software”, “a technology platform serving remote professionals”, “consumer commerce”) without naming a legal entity. Those descriptions are recorded here as self-described history and are not treated as evidence of a named entity, a revenue figure or an exit unless a separate source in the ledger establishes it.
Panel figures (4M+ companies, 48M company-years, 1.88B skill rows) are company statements about a proprietary dataset. No independent audit of those figures is recorded in this ledger.
The two testimonial statements are attributed and dated August 2026. They evidence that named third parties made those statements, not the accuracy of the assessments they contain.

Claims supported

Claim records

C-VIVAMEDA-001 Vivameda Ltd was incorporated in Cyprus on 15 July 2025 under company number HE 478035.
Verified by independent sourceSources:S-003 S-013
C-VIVAMEDA-002 Oliver Nold (Oli Nold) is CEO of Vivameda Ltd. The name “Oli Nold” used by third-party sources refers to the same person as “Oliver Nold” (canonical entity https://olivernold.com/#oliver-nold).
Publicly corroborated / first-party profileSources:S-014 S-012 S-013
C-VIVAMEDA-006 Vivameda Ltd operates a proprietary longitudinal workforce panel that the company states covers more than four million companies in over one hundred countries, 48 million observed company-years from 1950 to 2026, and 1.88 billion skill rows across 46.5 million capability buckets. These figures are the company's own statements about a proprietary dataset and are not independently audited in this ledger.
Company-controlled primary sourceSources:S-025 S-026 S-027 S-013
C-PUB-001 Vivameda Ltd published the document “Oliver Nold — Founder Portfolio” (control number VMD.21962.150826.301) in August 2026, a ten-page founder profile describing Oliver Nold's operating history, the company, its capability areas and its operating model.
Company-controlled primary sourceSources:S-025

S-025

Read the document (PDF, 96 KB)

pub-client-portfolio-2026 · VMD.21958.150826.240

Vivameda Client Portfolio 2026

Twenty engagements, three decision classes, February to August 2026.

Publisher: Vivameda Ltd, Cyprus
Author: Vivameda Ltd (Oliver Nold)
Issued: August 2026
Extent: 28 pages, PDF (212 KB)
Purpose: Engagement and field-evidence document reproducing twenty client engagements delivered between February and August 2026, grouped by the economic decision each was built to improve.
Evidence classification: Company-controlled primary source
Source record: S-026

Contents, as published

Overview — what the portfolio is, what is excluded, and how each entry is built.
Selection — sixty documents were produced across the period; twenty are reproduced, against a stated four-part inclusion criterion, one entry per counterparty.
Method — twelve recurring techniques (M01–M12), including negative-space filtering, the qualifying gate, two-column evidence, deliberate disqualification, dated signal anchoring, speed-to-close tiering, the withheld contact layer, signal killing, scope framing, the paired comparison and the published null.
Class one — acquisition, diligence and allocation: private equity, venture, sell-side M&A, quantitative and financing counterparties.
Class two — advisory and intermediation: consultancies, growth advisory, channel partners and recruitment intelligence.
Class three — operating growth and market development: demand generation, marketing consultancy, compliance software and sector samples.
Findings — what repeats across the twenty, and what the evidence rests on.

Figures stated in the document

Engagements reproduced: 20, February to August 2026
Documents produced across the period: 60
Entries recording a killed signal or published null: 6
Counterparty geographies: United States, United Kingdom, Germany, Switzerland, Italy, Netherlands, Benelux, Hong Kong

Reproduced as company statements. No independent audit of these figures is recorded in the source ledger.

How to read this document

All engagements ran under confidentiality arrangements. Counterparties are identified by category and geography only, and companies inside a counterparty's portfolio or target set are described rather than named. The document therefore cannot be independently verified counterparty by counterparty from its own contents.
Document titles are Vivameda's own, not the counterparties'.
The twenty entries are a stated non-random selection against a published inclusion criterion, not the complete engagement record.

Claims supported

Claim records

C-VIVAMEDA-006 Vivameda Ltd operates a proprietary longitudinal workforce panel that the company states covers more than four million companies in over one hundred countries, 48 million observed company-years from 1950 to 2026, and 1.88 billion skill rows across 46.5 million capability buckets. These figures are the company's own statements about a proprietary dataset and are not independently audited in this ledger.
Company-controlled primary sourceSources:S-025 S-026 S-027 S-013
C-PUB-002 Vivameda Ltd published the “Client Portfolio 2026” (control number VMD.21958.150826.240) in August 2026, reproducing twenty of sixty documents produced for counterparties between February and August 2026 under confidentiality, with counterparties identified by category and geography only.
Company-controlled primary sourceSources:S-026

S-026

Read the document (PDF, 212 KB)

pub-research-portfolio-2026 · VMD.21921.120826.224

Vivameda Research Portfolio 2026 (English edition)

Five studies, one longitudinal workforce panel.

Publisher: Vivameda Ltd, Cyprus
Author: Vivameda Ltd (Oliver Nold)
Issued: 2026; individual studies dated May to August 2026
Extent: 50 pages, PDF (9308 KB)
Purpose: Research document collecting five studies run on the Vivameda Longitudinal Workforce Panel, each with a stated method, validation approach and scope-of-application section.
Evidence classification: Company-controlled primary source
Source record: S-027

Contents, as published

Introduction — five applications of one dataset, and why workforce structure answers questions financial data cannot.
Study one — The Unicorn Signature: pre-hypergrowth patterns. Stated result: the top 1 per cent of scored companies enter hypergrowth at 27 times the base rate; six unicorns held out of training all scored in the top 30 per cent in the year before they scaled.
Study two — The Defensible Shelf: structural business vulnerability. Stated result: of 225 large retailers, 72 are gone; those with an online-substitutable assortment failed at 42.1 per cent against 7.6 per cent, a factor of 5.5, on seven workforce signals measured before 2017.
Study three — The Closed Circuit: capability and talent-network lock-in. Stated result: across seventy personnel-exchange relationships spanning six companies, no software house appears; eight of nine automotive units moved by less than 0.10 index points over a decade.
Study four — The 1998 Head Start: long-term organisational readiness. Stated result: across 41 multinationals, those already distributed in 1998 reduced workforce concentration almost ten times as much over the following twenty years, at an identical rate of entity growth; tested by permutation across 100,000 draws.
Study five — The Portable Asset: capability decay before failure. Stated result: of six AI companies in one identical window, the four that later contracted were thinning their engineering share by 2020 and the two that persisted were thickening theirs.
Closing section — how the same instrument is applied to a specific company list, market, portfolio or acquisition universe.

Figures stated in the document

Panel companies: 4M+ across 100+ countries
Observed company-years: 48M, covering 1950 to 2026
Skill rows: 1.88B on one taxonomy, 46.5M capability buckets
Studies: 5, dated May to August 2026

Reproduced as company statements. No independent audit of these figures is recorded in the source ledger.

How to read this document

The studies are published by the company that owns the panel. They are not peer-reviewed and no independent replication is recorded in this ledger. The document states that classification rules and queries are reproducible and disclosed on request.
Each study carries its own scope section. Headline figures reproduced here are the document's own statements and are not detached from those scope limits.
The document states that historical and current data layers are reported separately and never arithmetically combined, and that panel figures are observed workforce records on a uniform taxonomy rather than reported corporate headcount.

Claims supported

Claim records

C-VIVAMEDA-002 Oliver Nold (Oli Nold) is CEO of Vivameda Ltd. The name “Oli Nold” used by third-party sources refers to the same person as “Oliver Nold” (canonical entity https://olivernold.com/#oliver-nold).
Publicly corroborated / first-party profileSources:S-014 S-012 S-013
C-VIVAMEDA-006 Vivameda Ltd operates a proprietary longitudinal workforce panel that the company states covers more than four million companies in over one hundred countries, 48 million observed company-years from 1950 to 2026, and 1.88 billion skill rows across 46.5 million capability buckets. These figures are the company's own statements about a proprietary dataset and are not independently audited in this ledger.
Company-controlled primary sourceSources:S-025 S-026 S-027 S-013
C-PUB-003 Vivameda Ltd published the “Research Portfolio 2026” (control number VMD.21921.120826.224), collecting five studies run on its longitudinal workforce panel and dated May to August 2026: The Unicorn Signature, The Defensible Shelf, The Closed Circuit, The 1998 Head Start and The Portable Asset. The studies are company-published and are not peer-reviewed.
Company-controlled primary sourceSources:S-027

S-027

Read the document (PDF, 9308 KB)